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Several medicinal plants are known to possess anticoagulant activity. This study proposed to evaluate the in vitro 
anticoagulant effect of methanol extracts of Citrullus colocynthis (fruits), Achillea fragrantissima (aerial parts) and 
Artemisia herba-alba (aerial parts) on normal human plasma. A total of 100 blood samples used in this study were taken 
from healthy volunteers at the Hematology laboratory of King Khalid Hospital, Al-Majmaah, Kingdom of Saudi Arabia 
from November 2018 to March 2019, using 3.2% sodium citrate tubes with a collection ratio of 9:1 blood to anticoagulant. 
PT, INR and PTT were used to assess the anticoagulant activity of these plants. The highest PT results were observed for 
1000 µg/mL methanol extract of C. colocynthis (33.7±3.4 s) followed by 1000 µg/mL methanol extract of A. fragrantissima 
(28.2±2.6 s) and 1000 µg/mL methanol extract of A. herba-alba (26.4±0.2 s). Moreover, the highest PTT values were 
observed for 250, 500 and 1000 µg/mL A. fragrantissima (87.9±1.0, 97.9±5.1 and 112.5±1.1 s, respectively), 500 µg/mL 
and 1000 µg/mL C. colocynthis (65.1±1.0 and 106.4±0.4 s, respectively) and 1000 µg/mL A. herba-alba (157.0±3.0 s). 
The anticoagulant effect of methanol extracts of A. herba-alba, A. fragrantissima, and C. colocynthis were evaluated using 
coagulation assays, in which prolonged clotting time of their methanol extracts was observed. These findings potentially 
justify the use of these plants in managing arterial and venous thrombotic disorders. 
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Anticoagulant drugs such as heparin have been the 
backbone of the treatment of arterial and venous 
thrombotic conditions for decades, but they have some 
complications. Previous studies have indicated that a 
few medicinal plants are known for their anticoagulant 
activity, indicating a novel therapeutic approach to 
treating arterial and venous thrombotic disorders1-4. 
Artemisia herba-alba (Asteraceae) is a greyish 
strongly aromatic dwarf shrub, (Arabic name: chih5). 
A. herba-alba has broad range of uses in folk medicine,
namely, treatment of diarrhea and abdominal cramps,
external wound healing,6,7 treatment of helminthiasis,
diabetes mellitus and jaundice8. The pharmacological
properties of A. herba-alba extract include antidiabetic,9-12 
antimicrobial,13 antioxidant14,15 and antisickling
activities16.
Achillea fragrantissima (Asteraceae) is a wild 
herbaceous shrub17 that has several different common 
names depending on the country they are found in, 
such as Lavender cotton (English), Guarda roba 
(French) and Qaysūm (Arabic)18. It has been used in 
traditional medicine for the treatment of respiratory, 
skin and gastrointestinal diseases, hypertension, and 
diabetes19-21. Several reports demonstrated different 
pharmacological activities of A. fragrantissima 
extracts22-24. 
A. fragrantissima lacks anti-rheumatic or anti-
inflammatory effects in carrageenan-induced acute 
inflammation in rats25 but has antimicrobial and antiviral 
activities26,27. Its modulatory effects were observed on 
rat ileum muscle contraction28, and it is therefore useful 
in avoiding neurodegenerative diseases23. Aqueous 
extract of this herb exhibited strong cytotoxicity and 
larvicidal activities29,30. Antioxidant, antimicrobial, 
antiplatelet, anti-proliferative and acetylcholinesterase 
(AChE) inhibition efficacy of aqueous and hydro-
alcoholic extracts from A. fragrantissima grown in 
Jordan were studied31. 
—————— 
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Citrullus colocynthis (Cucurbitaceae) is a medicinal 
plant that has several different common names, such as 
colocynth, bitter apple, wild gourd and the Arabic names 
Handal and Hhanzal. The fruit of C. colocynthis contains 
a bitter glycoside, which has ample medicinal values. 
Aqueous and methanol extracts of C. colocynthis 
showed high antimicrobial activity as well as anticancer, 
proapoptotic, and antidiabetic properties32-35. 
Several studies reported anticoagulant effects of 
plant extracts and their chemical constituents1-4,36,37. 
The reason of selecting these three plant species to 
test their anticoagulant activity is because there are no 
published studies displaying the in vitro anticoagulant 
effect of these three plant species. Therefore,  
this study was proposed to evaluate the in vitro 
anticoagulant effect of methanol extracts of A. herba-
alba, A. fragrantissima and C. colocynthis on normal 
human plasma.  
In vitro anticoagulant effect of methanol extracts of  
A. herba-alba Asso, A. fragrantissima, and C. colocynthis 
was evaluated by measuring prothrombin time (PT), 
international normalized ratio (INR) and partial 
thromboplastin time (PTT). These were determined for 




Procedure for the formation of plant methanol extracts 
In our current research, A. fragrantissima (aerial 
parts), A. herba-alba (aerial parts) and C. colocynthis 
(fruits) were collected from Al Majmaah Riyadh 
region, Saudi Arabia in December 2017. All plant 
parts were dried under the same conditions. Dried 
plant samples were ground in the same blender for 
preparing identical size of the powder. Thereafter,  
100 g of powder was added in 1 L of 80% CH3OH 
(methanol) for 1 week at room temperature. A wide 
range of phyto-chemical compounds both polar and 
non-polar are brought out by methanol easily because 
methanol contains both polar and non polar groups 
which make it able to extract both polar and non polar 
compounds. Another reason is the low boiling point 
of methanol. It helps to evaporate the filtrate within a 
short time. Moreover, methanol is less carcinogenic 
than other solvents. Also the market price is less than 
other solvents.  
The mixture was filtered and the filtrate was 
vaporized with the help of rotary evaporator for 
removal of CH3OH at 50°C under reduced pressure. 
Now we get the final dry crude extract in the dark 
color glass bottle for further use in research study at 
refrigerator. 0.1 g/mL (stock solution) of crude extract 
was formed by dissolving 0.1 g of dry crude extract in 
1 mL dimethylsulfoxide (DMSO) and we further 
diluted in 9 mL 0.9% NaCl. For 5 days, this stock 
solution was kept in refrigerator. 
 
Collection of blood samples  
Properly collected specimen leads to good blood 
test result, so blood sample should be collected into a 
tube with oxalate or citrate ions to remove the calcium 
from plasma sample to prevent the clotting process 
from beginning before the test (Prothrombin Time test 
and partial thromboplastin time test) and that's 
because PT and PTT test check if blood clotting 
factors are present.  
A total of 100 blood samples were taken from healthy 
volunteers at the Hematology Laboratory of King Khalid 
Hospital, Al-Majmaah, Kingdom of Saudi Arabia from 
November 2018 to March 2019. Informed consent  
was obtained from each study subject prior to their 
participation in the research. The blood samples were 
collected using 3.2% sodium citrate tubes with a 
collection ratio of 9:1 blood to anticoagulant. These 
sodium citrate tubes were filled completely. Samples 
were gently mixed after collection and stored for a 
maximum of 1 h. All procedures were in accordance to 
ethical standards of the Ethical Committee, King Fahad 
Medical City, Ministry of Health, Kingdom of Saudi 





Preparation of platelet poor plasma (PPP) 
Sodium citrate tubes were centrifuged to get PPP 
by centrifugation at 2000 ×g for 15 min to separate 
plasma. The plasma samples were stored at 4°C until 
required for further use. 
 
Anticoagulant activity evaluation 
In order to evaluate the anticoagulant effect of 
plant extracts, in vitro anticoagulant assay was 
performed as follows: 
To evaluate the extrinsic pathway of coagulation, 
PT and INR tests were performed, using normal 
human plasma. To evaluate the intrinsic pathway of 




The extrinsic pathway was assessed using the PT 
test, with some modifications38. Plasma (500 µL)  
was mixed with 500 µL of different concentrations 




(250, 500, 1000 and 10000 µg/mL) of crude 
extracts and incubated for 60 min at 37°C. 
Thereafter, the pre incubated plasma was used for 
determination the PT test and this was carried out 
using a coagulation analyzer (Sysmex CA-1500) in 
the hematology lab at King Khalid Hospital in  




The extrinsic pathway was also evaluated using the 
INR test, with some modifications38. Plasma (500 µL 
was mixed with 500 µL of different concentrations  
(250, 500, 1000 and 10000 µg/mL) of crude extracts and 
incubated for 60 min at 37°C. Thereafter, the pre 
incubated plasma samples were used for determination 
the INR test and this was carried out using a coagulation 
analyzer (Sysmex CA-1500) in the hematology lab at 
King Khalid Hospital in AL-Majmaah. 0.9% NaCl was 
used as the negative control. 
 
PTT test 
The action in intrinsic and common pathways  
was assessed using the PTT test, with some 
modifications38. Plasma (500 µL) was mixed with  
500 µL of different concentrations (250, 500, 1000 
and 10000 µg/mL) of crude extracts and incubated for 
60 min at 37°C. Thereafter, the preincubated plasma 
was used for determination via the PTT test and this 
was carried out using a coagulation analyzer (Sysmex 
CA-1500) in the hematology lab at King Khalid 
Hospital in AL-Majmaah. NaCl (0.9%) was used as 
the negative control. 
A stock solution (10 µg/mL) of plant extract was 
formed by suspending 0.1 g of dry extract of each 
plant in 1 mL of 100% DMSO, prior diluted to 10 mL 
with normal saline. Then we formed 3 dilutions (250, 




Data were analyzed by using SPSS (Statistical 





The yields (g extract/100 g dry plant part) of 
studied plants are shown in Table 1. The extraction 
yield varied from the highest yield of 19.0% in  
A. herba-alba to the lowest yield of 5.0% in  
C. colocynthis. 
Anticoagulant activity of methanol extracts of studied plants  
The anticoagulant activity of plant extracts was 
evaluated by PT, INR and PTT assays, using normal 
human plasma. 
 
Effect of methanol extracts of studied plants on PT 
To evaluate the extrinsic pathway of coagulation, 
the PT assay was done, using normal human plasma. 
Table 2 shows PT results after incubation of 
normal human plasma with 0.9% NaCl (control) and 
with 250, 500 and 1000 µg/mL of crude extracts of A. 
herba-alba (aerial parts), A. fragrantissima (aerial 
parts) and C. colocynthis (fruits).  
As shown in Table 2, the highest PT result was 
observed for 1000 µg/mL of methanolic extract of  
C. colocynthis (fruits) (33.7±3.4 s) followed by  
1000 µg/mL of methanol extract of A. fragrantissima 
(aerial parts) (28.2±2.6 s) and 1000 µg/mL of 
methanol extract of A. herba-alba (aerial parts) 
(26.4±0.2 s). Moreover, a significant increase in PT 
results, compared to the control, was observed at 
concentrations of 500 and 1000 µg/mL of methanol 
extracts of A. fragrantissima and A. herba-alba. 
These findings indicate the significant anticoagulant 
effect of these plants. Significant increase in PT 
results was also observed at 250, 500 and 1000 µg/mL 
of methanol extracts of C. colocynthis, which also 
proved its anticoagulant activity. 
 
Effect of methanol extract of studied plants on PTT of normal 
human plasma 
To evaluate the intrinsic pathway of coagulation, 
the PTT assay was done, using normal human plasma. 
Table 3 shows PTT results after incubation of 
normal human plasma with 0.9% NaCl (control), and 
with 250, 500 and 1000 µg/mL of crude extracts of  
A. herba-alba (aerial parts), A. fragrantissima (aerial 
parts) and C. colocynthis (fruits).  
As shown in Table 3, the highest PTT values were 
observed at 250, 500, and 1000 µg/mL concentrations of 
methanol extract of A. fragrantissima (87.9±1.0, 
97.9±5.1 and 112.5±1.1 s, respectively). High PTT 
values were also observed at 500 and 1000 µg/mL 
concentrations of methanol extract of C. colocynthis 
(65.1±1.0 and 106.4±0.4 s, respectively) and at  
Table 1 — Percentage (%) yield (g extract/100 g dry plant part) of 
studied plant species 
Plant species % Yield 
Achillea fragrantissima (Forssk) Sch. Bip (aerial parts) 12.0 
Artemisia herba-alba Asso (aerial parts) 19.0 
Citrullus colocynthis (L.) Schrad (fruits) 5.0 
 




1000 µg/mL concentration of methanol extract of  
A. herba-alba (157.0±3.0 s). 
 
Effect of methanol extracts of studied plants on INR  
Table 4 shows INR values after incubation of 
normal human plasma with 0.9% NaCl (control) and 
with 250, 500 and 1000 µg/mL of crude extract of  
A. herba-alba (aerial parts), A. fragrantissima (aerial 
parts) and C. colocynthis (fruits). 
As shown in Table 4, the highest INR value was 
observed for 1000 µg/mL of methanol extract of  
C. colocynthis (2.9±0.3) followed by 1000 µg/mL of 
methanol extract of A. fragrantissima (2.5±0.2) and 
by 1000 µg/mL of methanol extract of A. herba-alba 
(2.3±0.01).  
A significant increase in INR results, compared to 
the control, was observed at concentrations of 500 and 
1000 µg/mL of methanol extracts of A. fragrantissima, 
A. herba-alba and C. colocynthis. These findings 
indicated significant anticoagulant activity of methanol 
extracts of the studied plants. 
 
Discussion 
Previous studies reported that medicinal plants 
possess anticoagulant activity, contributing to the 
treatment of arterial and venous thrombotic disorders. 
The present study evaluates the in vitro anticoagulant 
effect of C. colocynthis (fruits), A. fragrantissima 
(aerial parts) and A. herba-alba (aerial parts) 
Table 2 — Effect of methanol extract of studied plants on Prothrombin Time (PT) of normal human plasma 
Plant Species  Prothrombin Time (PT) in seconds 
 Plasma  
+ 250 µg/mL 
Plasma  
+ 500 µg/mL 
Plasma  
+ 1000 µg/mL 
Plasma  
+ normal saline (Control) 
Achillea fragrantissima  13.3 ± 1.0 20.1 ± 1.7 28.2 ± 2.6 13.7±0.9 
P value 0.5830 0.0047 0.0008  
Artemisia herba-alba  13.6 ± 1.4 15.3 ± 1.6 26.4 ± 0.2 11.5 ± 0.2 
P value 0.0668 0.0154 0.0001  
Citrullus colocynthis  14.1 ± 0.6 16.5 ± 0.3 33.7 ± 3.4 11.7 ± 0.5 
P value 0.0076 0.0002 0.0004  
Each value represents the mean value ± S.D., (n =3), p value ≤0.05 was considered significant, compared to the control. 
 
Table 3 — Effect of methanol extract of studied plants on Partial Thromboplastin Time (PTT) of normal human plasma 
Plant Species  Partial Thromboplastin Time (PTT) in seconds 
 Plasma  
+ 250 µg/mL 
Plasma  




+ normal saline (control) 
Achillea fragrantissima  87.9 ± 1.0 97.9 ± 5.1 112.5 ± 1.1 58.1 ± 1.6 
P value 0.0001 0.0002 0.0001  
Artemisia herba-alba  56.0 ± 0.4 56.9 ± 1.0 157.0 ± 3.0 58.1 ± 1.6 
P value 0.0962 0.3392 0.0001  
Citrullus colocynthis  NM 65.1 ± 1.0 106.4 ± 0.4 52.1 ± 0.8 
P value ND 0.0001 0.0001  
Each value represents the mean value ± S.D., (n =3), p value ≤0.05 was considered significant, compared to the control. NM indicates 
not measured. 
 
Table 4 — Effect of methanol extract of studied plants on International Normalized Ratio (INR) of normal human plasma 
Plant Species  International Normalized Ratio (INR) in seconds 
 Plasma + 250 µg/mL Plasma  
+ 500 µg/mL 
Plasma  
+ 1000 µg/mL 
Plasma  
+ normal saline (control) 
Achillea fragrantissima  1.2 ± 0.2 1.8 ± 0.1 2.5 ± 0.2 1.2 ± 0.1 
P value 0.5857 0.0047 0.0008  
Artemisia herba-alba  1.2 ± 0.1 1.3 ± 0.1 2.3 ± 0.01 1.0 ± 0.01 
P value 0.0649 0.0142 0.0001  
Citrullus colocynthis  1.2 ± 0.05 1.5 ± 0.006 2.9 ± 0.3 1.04 ± 0.04 
P value 0.0069 0.0001 0.0004  
Each value represents the mean value ± S.D., (n =3), p value ≤0.05 was considered significant, compared to the control. 
 




methanol extracts. The anticoagulant activity of plant 
extracts was evaluated by the PT, INR and PTT 
assays, using normal human plasma. 
After incubation of normal human plasma with 
0.9% NaCl (control), and with 250, 500 and 1000 
µg/mL of crude extract of A. herba-alba (aerial parts), 
A. fragrantissima (aerial parts) and C. colocynthis 
(fruits), the highest PT and INR results were observed 
for 1000 µg/mL of methanol extract of C. colocynthis 
(fruits) (33.7±3.4 s, 2.9±0.3) followed by 1000 µg/mL 
of methanol extract of A. fragrantissima (aerial parts) 
(28.2±2.6 s, 2.5±0.2) and by 1000 µg/mL of methanol 
extract of A. herba-alba (aerial parts) (26.4±0.2 s, 
2.3±0.01). These results indicate that the methanol 
extracts of studied plants prolonged clotting time as 
recorded via the PT test and this prolongation of PT 
indicates the inhibition of the extrinsic and/or 
common pathway of coagulation, demonstrating their 
anticoagulant activity. 
These findings coincide with the findings of 
previous studies1-4,36,37. A significant increase in PT 
results, compared to the control, was observed at 
concentrations of 500 and 1000 µg/mL of methanol 
extracts of A. fragrantissima and A. herba-alba. 
These findings indicate the significant anticoagulant 
activity of these plants. A significant increase in PT 
results was also observed at 250, 500 and 1000 µg/mL 
of methanol extracts of C. colocynthis, also proving 
its anticoagulant activity. 
After incubation of normal human plasma with 
0.9% NaCl (control) and with 250, 500 and 1000 
µg/mL of crude extract of A. herba-alba (aerial parts), 
A. fragrantissima (aerial parts) and C. colocynthis 
(fruits), the highest PTT values were observed at 250, 
500 and 1000 µg/mL concentrations of methanol 
extracts of A. fragrantissima (87.9±1.0, 97.9±5.1 and 
112.5±1.1 s, respectively). The methanol extracts of 
A. fragrantissima were able to prolong the clotting 
time observed via the PTT test, indicating its 
anticoagulant activity. High PTT values were also 
observed at 500 and 1000 µg/mL concentrations of 
methanolic extracts of C. colocynthis (65.1±1.0 and 
106.4±0.4 s, respectively). These findings indicated 
significant anticoagulant activity of C. colocynthis. 
High PTT values were observed at 1000 µg/mL 
concentration of methanol extracts of A. herba-alba 
(157.0±3.0 s). The methanol extracts of A. herba-alba 
were able to prolong the clotting time in the PTT test only 
at high concentration, indicating its anticoagulant activity. 
The methanol extracts of studied plants were able 
to prolong the clotting time in the PTT test. This 
prolongation of PTT indicates the inhibition of the 
intrinsic and/or common pathway of coagulation 
demonstrating their anticoagulant activity. These 
findings coincide with the findings of a previous 
study4,36,37. 
Our findings in the current study revealed that the 
three methanol extracts of studied plants showed 
anticoagulant activity via inhibition of coagulation 
pathways. Further studies are recommended to 
identify the active constituents in each plant extract 
that may be responsible for the anticoagulant activity 
of these three plants. 
 
Conclusion 
The present study demonstrated that methanol 
(aerial parts, fruits) extract of A. herba-alba,  
A. fragrantissima, and C. colocynthis possesses 
significant in vitro anticoagulant activity. These 
findings potentially justified the use of this plant in 
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